Critical supporting codes that should accompany the E66 primary diagnosis include: Z68.30 through Z68.45 - BMI codes specifying the exact range (Z68.35 = BMI 35.0-35.9, Z68.41 = BMI 41.0-44.9, etc.) I10 - Essential hypertension (a qualifying comorbidity) E78.5 - Hyperlipidemia, unspecified (another qualifying comorbidity) G47.33 - Obstructive sleep apnea (a qualifying comorbidity) E11.9 - Type 2 diabetes (if present as comorbidity) Loading the claim with all applicable comorbidity codes significantly improves the chances of first-pass approval
GLP-1 receptor agonist Targets appetite and glucose regulation at the neurological level
In these conditions, bowel thickening and inflammation leads to poor absorption of nutrients and weight loss
We believe in the hustle, the grind, the relentless push for greatness
Appetite suppression and weight loss are hallmark stimulant effects
These include enhanced physical functioning, as well as lowered C-reactive protein levels which indicates reduced inflammation